1. Home
  2. PRQR vs TMCI Comparison

PRQR vs TMCI Comparison

Compare PRQR & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.69

Market Cap

173.8M

Sector

Health Care

ML Signal

HOLD

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$2.52

Market Cap

174.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRQR
TMCI
Founded
2012
2014
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
173.8M
174.6M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
PRQR
TMCI
Price
$1.69
$2.52
Analyst Decision
Strong Buy
Hold
Analyst Count
7
5
Target Price
$8.14
$4.21
AVG Volume (30 Days)
537.7K
707.1K
Earning Date
03-12-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,859,556.00
$218,879,000.00
Revenue This Year
N/A
$3.30
Revenue Next Year
$18.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.90
52 Week Low
$1.07
$2.36
52 Week High
$3.10
$10.79

Technical Indicators

Market Signals
Indicator
PRQR
TMCI
Relative Strength Index (RSI) 37.79 38.10
Support Level $1.58 $2.56
Resistance Level $1.80 $2.75
Average True Range (ATR) 0.14 0.17
MACD 0.00 0.01
Stochastic Oscillator 13.67 14.62

Price Performance

Historical Comparison
PRQR
TMCI

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: